|
 Dementia
 Merz - our research for your health. In studies of memantine, doctors assessed tolerability as good or very good in 93 percent of patients.
Dementia: learn more about the different forms of diseases, current research, drugs, treatment, therapies and care. Dementia is a topic that anyone of us should think about, because when growing old, everyone could be affected. Inform yourself about Dementia now! The care for elderly people and their diseases are a topic for our society, whose importance grows each day. That's why we at Merz take Dementia very serious, so that we can offer you the best drug for each treatment and therapy you need. Dementia and Merz means research for your health. High-quality products and information about Dementia can be found on our website. Visit us online and learn everything about Dementia from one of Germany's leading health care companies. Our contribution to Dementia: read here what we can do for you. Further links: Axura: Information for professionals.>>>
The care for elderly people and their diseases are a topic for our society, whose importance grows each day.
Memantine , Alzheimer's Treatment . Calcium enters into the cell, and through secondary processes, the signal is recognized. Such excitotoxicity ultimately leads to neuronal calcium overload and has been implicated in neurodegenerative disorders. Senile Dementia , Dementia Care . As memantine, in contrast to magnesium, blocks the NMDA receptor in the presence of sustained release of low glutamate concentrations, the influx of calcium is prevented (neuroprotection). If you have questions regarding Memantine, Axura or Namenda, please contact the responsible department. A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. The starting point is the pathological release of glutamate, followed by elevated calcium concentrations. Alzheimer's Research , Alzheimer . There is a continuous influx of calcium into the cell, increasing the calcium pool. Dysfunction of glutamatergic neurotransmission is involved in pathomechanism of neurodegenerative dementia. At the same time, Memantine reduces caregiver time by more than 50 hours a month. A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. Demenzkranke , Verwirrtheit Gedächtnisstörungen Short Term Memory Loss Symptoms Of Alzheimer's Disease . Therefore memantine has a low potential for day-day interactions in these multimorbid patients. Alzheimer Erkrankung , Symptoms Of Alzheimer's Alzheimer's Disease Symptoms . Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. The excitatory neurotransmitter glutamate plays an important part in the development of neurodegenerative diseases like dementia. Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Glutamate is the principal neurotransmitter in the brain. In studies of memantine, doctors assessed tolerability as good or very good in 93 percent of patients. Alzheimer's Drug Dementia Symptoms , Hirnleistungsstörungen . About 70 percent of all excitatory synapses in the central nervous system are stimulated by the neurotransmitter glutamate. Glutamatergic overstimulation results in neuronal damage, a phenomenon that has been termed excitotoxicity. Merz is a leader in the field of Alzheimer research and developed the first drug for the treatment of moderate to severe Alzheimer s. Memantine is a NMDA receptor antagonist and protects the glutamatergic system from pathological activation. Clinically-relevant doses of memantine produce improvements in learning under conditions of tonic NMDA receptor activation in Alzheimer's disease. Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. Demenz Krankheit Alzheimer Behandlung NMDA-Schutz Demenz Früherkennung , Mild Cognitive Impairment Altersdemenz . As memantine, in contrast to magnesium, blocks the NMDA receptor in the presence of sustained release of low glutamate concentrations, the influx of calcium is prevented (neuroprotection). Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. The safety of the combination therapy was investigated in a postmarketing surveillance study. Alzheimer und Demenz , Glutamate Demenz Behandlung Demenz-Erkrankung . The starting point is the pathological release of glutamate, followed by elevated calcium concentrations. Glutamatergic overstimulation results in neuronal damage, a phenomenon that has been termed excitotoxicity. At the same time, Memantine reduces caregiver time by more than 50 hours a month. Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Alzheimer's Disease Alzheimer Therapie , Symptoms Of Dementia . Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. NMDA-Antagonist Forgetfulness , Glutamat Alzheimer Früherkennung . This is clearly discernible behind the low background noise. vaskuläre Demenz , Lewy Body Dementia Demenz Therapie Vascular Dementia . The excitatory neurotransmitter glutamate plays an important part in the development of neurodegenerative diseases like dementia. Recent results from a Phase III trial show that patients receiving a combination of memantine and donepezil performed significantly better than patients receiving donepezil and placebo. Gedächtnis , Demenz . Merz , Multi Infarct Dementia . Alzheimer's Dementia Axura , Vergesslichkeit Antidementiva Alzheimer's Caregiver . Therefore memantine has a low potential for day-day interactions in these multimorbid patients. The safety of the combination therapy was investigated in a postmarketing surveillance study. Stages Of Alzheimer's Disease , Akatinol Alzheimer's Support Hirnleistungsstörung NMDA-Protection . About 70 percent of all excitatory synapses in the central nervous system are stimulated by the neurotransmitter glutamate. Due to its strong voltage-dependency, magnesium leaves the NMDA receptor. Alzheimer's , Demenzerkrankung Dementia . Glutamate is the principal neurotransmitter in the brain. Memory Loss Pseudodemenz Alzheimer's Care , Dementia Treatment . Memantine is the first representative of a new class of Alzheimer drugs, a moderate affinity NMDA-receptor antagonist. Dementia And Alzheimer's Alzheimer Krankheit , Demenzkrank . Alzheimer's Symptoms , Mental Confusion . Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Glutamate is the principal neurotransmitter in the brain. Dementia Medication Literatur , Erkennung Diagnose Studien . Memantine is well tolerated even in long-term therapy. Memantine is well tolerated even in long-term therapy. Medikamentkombinationen , Demenz Medikament . Therapy , Help . Diagnosis , Information Literature . Studies , Combination . Treatment Alzheimer's Therapie Demenz Alzheimer Medikament , Medication Alzheimer's .
 Dementia
|
